Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
2.980
-0.060 (-1.97%)
Aug 24, 2026, 4:00 PM EDT - Market closed
Elicio Therapeutics Employees
Elicio Therapeutics had 33 employees as of December 31, 2025. The number of employees increased by 1 or 3.13% compared to the previous year.
Employees
33
Change (1Y)
1
Growth (1Y)
3.13%
Revenue / Employee
n/a
Profits / Employee
-$1,146,697
Market Cap
78.32M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 33 | 1 | 3.13% |
| Dec 31, 2024 | 32 | 0 | - |
| Dec 31, 2023 | 32 | 9 | 39.13% |
| Dec 31, 2022 | 23 | -1 | -4.17% |
| Dec 31, 2021 | 24 | 2 | 9.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Verrica Pharmaceuticals | 76 |
| Cardiff Oncology | 31 |
| NeurAxis | 24 |
| Cingulate | 14 |
| MAIA Biotechnology | 13 |
| Eloxx Pharmaceuticals | 10 |
| Alterity Therapeutics | 9 |
| Annovis Bio | 7 |
ELTX News
- 21 hours ago - Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference - GlobeNewsWire
- 8 days ago - Elicio Therapeutics reports Q2 EPS (43c), consensus (54c) - TheFly
- 11 days ago - Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 11 days ago - Elicio Therapeutics Quarterly report: Q2 2026 - Filings
- 11 days ago - Elicio Therapeutics Earnings release: Q2 2026 - Filings
- 7 weeks ago - Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering - GlobeNewsWire
- 7 weeks ago - Elicio Therapeutics announces pricing of $15M registered direct offering - TheFly
- 7 weeks ago - Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering - GlobeNewsWire